Two injections in total and 3 ml autologous adipose-tissue-derived progenitor cells(haMPCs) for each injection; time-points for intervention: 1) initial injection; 2) 3 weeks following initial injection. The trial duration is 3 months.

Read more: http://www.clinicaltrials.gov/ct2/show/NCT01809769?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30